Makassed General Hospital’s (MGH) Hematology-Oncology Division and Bone Marrow Transplant Center is a leading facility in Lebanon, dedicated to providing comprehensive care for patients with hematological and oncological diseases. Established in 1996 in affiliation with l’Ecole des Sciences du Cancer Gustave Roussy (Paris, France), the center aims to financially support disadvantaged patients in their battle against cancer.
The increase in diagnosed cancer patients prompted the expansion of this center. Notably, MGH performed the first successful autologous bone marrow transplant in Lebanon in 1997. For over two decades, the facility has ensured cancer prevention, early detection, diagnosis, and treatment, leading to excellence in patient care and an increasing number of patients.
The center is comprised of:
- Five specialized hematology and oncology physicians.
- A highly active bone marrow growth program (BMT unit includes 100% sterile rooms with laminar airflow).
- A one-day chemotherapy clinic with 13 beds and a conventional chemotherapy unit with 12 beds.
- A fellowship program in affiliation with Beirut Arab University (BAU).
- Specialized hematology, microbiology, blood transfusion medicine, and cell therapy units developed at MGH.
- A comprehensive Hematology-Oncology nursing program.
Frequently asked questions
The center offers comprehensive care for hematological and oncological diseases, including cancer prevention, early detection, diagnosis, and treatment. Services include chemotherapy (conventional and one-day clinics), immunotherapy, guided treatments, blood transfusions, stem cell collection, and bone marrow transplants (autologous and from others). It also provides specialized units for hematology, microbiology, blood transfusion medicine, and cell therapy.
The Bone Marrow Transplant Center was established in November 1996 in affiliation with l’Ecole des Sciences du Cancer Gustave Roussy (Paris, France). In 1997, MGH performed the first successful autologous bone marrow transplant in Lebanon, making it the first unit of its kind in Lebanon for adult and pediatric cancer cases.
Yes, the Hematology-Oncology Division collaborates with the Children’s Cancer Center in Lebanon (CCCL) to provide treatment for pediatric cancer patients. Eight dedicated rooms are designed to reduce the suffering of children with diagnosed cancer cases, and the center offers annual treatments for over 700 children aged newborn to 18 years.
The center offers a fellowship program in affiliation with Beirut Arab University (BAU). It also includes a comprehensive Hematology-Oncology nursing program. The expertise of the division extends through its five specialized physicians.